These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34677186)

  • 21. Severe Fontan-Associated Liver Disease and Its Association With Mortality.
    Guerrero-Chalela CE; Therrien J; Grossman Y; Guo L; Liu A; Marelli A
    J Am Heart Assoc; 2023 Oct; 12(19):e024034. PubMed ID: 37776221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of Fontan-associated liver disease.
    Dillman JR; Trout AT; Alsaied T; Gupta A; Lubert AM
    Pediatr Radiol; 2020 Oct; 50(11):1528-1541. PubMed ID: 32809067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying and visualizing abdominal hemodynamics in patients with Fontan circulation by 4D phase-contrast flow magnetic resonance imaging at 1.5 T.
    Salehi Ravesh M; Langguth P; Moritz JD; Rinne K; Harneit PL; Schulze-Nagel J; Graessner J; Uebing A; Jansen O; Both M; Hansen JH
    Int J Cardiol; 2024 Oct; 413():132391. PubMed ID: 39059472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of Fontan-associated liver disease in Japan: Results from a nationwide survey in 2021.
    Ohfuji S; Tanaka A; Kogiso T; Kanto T
    Hepatol Res; 2024 Oct; 54(10):931-941. PubMed ID: 38526972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance of Fontan Associated Liver Disease in Childhood and Adolescence.
    Hansen JH; Khodami JK; Moritz JD; Rinne K; Voges I; Scheewe J; Kramer HH; Uebing A
    Semin Thorac Cardiovasc Surg; 2022; 34(2):642-650. PubMed ID: 33979666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of hepatocellular carcinoma arising from Fontan-associated liver disease.
    Sagawa T; Kogiso T; Sugiyama H; Hashimoto E; Yamamoto M; Tokushige K
    Hepatol Res; 2020 Jul; 50(7):853-862. PubMed ID: 32219953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fontan-associated liver disease: A review.
    Gordon-Walker TT; Bove K; Veldtman G
    J Cardiol; 2019 Sep; 74(3):223-232. PubMed ID: 30928109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fontan-associated liver disease and hepatocellular carcinoma in adults.
    Kogiso T; Tokushige K
    Sci Rep; 2020 Dec; 10(1):21742. PubMed ID: 33303924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic and prognostic associations of liver fibrosis scores in Fontan-associated liver disease.
    Martin de Miguel I; Kamath PS; Egbe AC; Jain CC; Cetta F; Connolly HM; Miranda WR
    Heart; 2023 Mar; 109(8):619-625. PubMed ID: 36581444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient liver elastography in the follow-up of Fontan patients: results of a nation wide survey in Germany.
    Meyer Z; Haas N; Mühlberg R; Braun A; Fischer M; Mandilaras G
    Front Pediatr; 2023; 11():1194641. PubMed ID: 37711600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing liver stiffness with conventional cut-off values overestimates liver fibrosis staging in patients who received the Fontan procedure.
    Cho Y; Kabata D; Ehara E; Yamamoto A; Mizuochi T; Mushiake S; Kusano H; Kuwae Y; Suzuki T; Uchida-Kobayashi S; Morikawa H; Amano-Teranishi Y; Kioka K; Jogo A; Isoura Y; Hamazaki T; Murakami Y; Tokuhara D
    Hepatol Res; 2021 May; 51(5):593-602. PubMed ID: 33677839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fontan-Associated Liver Disease: Evidence for Early Surveillance of Liver Health in Pediatric Fontan Patients.
    Rathgeber SL; Harris KC
    Can J Cardiol; 2019 Feb; 35(2):217-220. PubMed ID: 30760429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient elastography may identify Fontan patients with unfavorable hemodynamics and advanced hepatic fibrosis.
    Wu FM; Opotowsky AR; Raza R; Harney S; Ukomadu C; Landzberg MJ; Valente AM; Breitbart RE; Singh MN; Gauvreau K; Jonas MM
    Congenit Heart Dis; 2014; 9(5):438-47. PubMed ID: 24418160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: The VALDIG Fonliver prospective cohort.
    Téllez L; Rodríguez de Santiago E; Minguez B; Payance A; Clemente A; Baiges A; Morales-Arraez D; La Mura V; Llop E; Garrido E; Garrido-Lestache E; Tasayco S; Bruno O; Prieto R; Montserrat S; Pons M; Olavarría A; Dos L; Legendre A; Jesús Del Cerro M; Bañares R; García-Pagán JC; Rautou PE; Albillos A;
    J Hepatol; 2020 Apr; 72(4):702-710. PubMed ID: 31726116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Big Data in Transplantation Practice-the Devil Is in the Detail-Fontan-associated Liver Disease.
    Kim MH; Nguyen A; Lo M; Kumar SR; Bucuvalas J; Glynn EF; Hoffman MA; Fischer R; Emamaullee J
    Transplantation; 2021 Jan; 105(1):18-22. PubMed ID: 32639398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive assessment of liver abnormalities in pediatric Fontan patients.
    De Bruyne R; Vandekerckhove K; Van Overschelde H; Hendricx F; Vande Walle C; De Groote K; Panzer J; De Wolf D; Van Biervliet S; Bové T; François K
    Eur J Pediatr; 2022 Jan; 181(1):159-169. PubMed ID: 34231051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Research priorities in Fontan-associated liver disease.
    Khan S; Aziz H; Emamaullee J
    Curr Opin Organ Transplant; 2020 Oct; 25(5):489-495. PubMed ID: 32833705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Factors for Mid-Term Liver Disease After the Fontan Procedure.
    Oka N; Miyamoto T; Tomoyasu T; Hayashi H; Miyaji K
    Int Heart J; 2020 Sep; 61(5):979-983. PubMed ID: 32921662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of gamma-glutamyl transferase elevation in patients with Fontan-associated liver disease.
    Kogiso T; Ogasawara Y; Taniai M; Shimada E; Inai K; Tokushige K; Nakai Y
    Hepatol Res; 2024 Jul; ():. PubMed ID: 38985389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-cell multiomics guided mechanistic understanding of Fontan-associated liver disease.
    Hu P; Rychik J; Zhao J; Bai H; Bauer A; Yu W; Rand EB; Dodds KM; Goldberg DJ; Tan K; Wilkins BJ; Pei L
    Sci Transl Med; 2024 Apr; 16(744):eadk6213. PubMed ID: 38657025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.